These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

628 related items for PubMed ID: 22366800

  • 1. A representative cohort of patients with non-progressive multiple sclerosis at the age of normal life expectancy.
    Skoog B, Runmarker B, Winblad S, Ekholm S, Andersen O.
    Brain; 2012 Mar; 135(Pt 3):900-11. PubMed ID: 22366800
    [Abstract] [Full Text] [Related]

  • 2. Natural history of multiple sclerosis: a unifying concept.
    Confavreux C, Vukusic S.
    Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
    [Abstract] [Full Text] [Related]

  • 3. Relapses and progression of disability in multiple sclerosis.
    Confavreux C, Vukusic S, Moreau T, Adeleine P.
    N Engl J Med; 2000 Nov 16; 343(20):1430-8. PubMed ID: 11078767
    [Abstract] [Full Text] [Related]

  • 4. The natural history of primary progressive multiple sclerosis.
    Koch M, Kingwell E, Rieckmann P, Tremlett H.
    Neurology; 2009 Dec 08; 73(23):1996-2002. PubMed ID: 19996074
    [Abstract] [Full Text] [Related]

  • 5. The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease.
    Kremenchutzky M, Rice GP, Baskerville J, Wingerchuk DM, Ebers GC.
    Brain; 2006 Mar 08; 129(Pt 3):584-94. PubMed ID: 16401620
    [Abstract] [Full Text] [Related]

  • 6. Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis.
    Patti F, Amato MP, Bastianello S, Caniatti L, Di Monte E, Ferrazza P, Goretti B, Gallo P, Morra VB, Lo Fermo S, Picconi O, Tola MR, Trojano M, COGIMUS Study Group.
    Mult Scler; 2010 Jan 08; 16(1):68-77. PubMed ID: 19995846
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes.
    Zipoli V, Goretti B, Hakiki B, Siracusa G, Sorbi S, Portaccio E, Amato MP.
    Mult Scler; 2010 Jan 08; 16(1):62-7. PubMed ID: 19995837
    [Abstract] [Full Text] [Related]

  • 9. Age at disability milestones in multiple sclerosis.
    Confavreux C, Vukusic S.
    Brain; 2006 Mar 08; 129(Pt 3):595-605. PubMed ID: 16415309
    [Abstract] [Full Text] [Related]

  • 10. Benign multiple sclerosis in Crete.
    Mastorodemos V, Nikolakaki H, Tzagournissakis M, Kotzamani D, Panou T, Spanaki C, Klados G, Maris T, Kontolaimaki E, Psaroudaki K, Chlouverakis G, Georgakakis G, Plaitakis A.
    Mult Scler; 2010 Jun 08; 16(6):701-6. PubMed ID: 20237192
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Brain lesion location and clinical status 20 years after a diagnosis of clinically isolated syndrome suggestive of multiple sclerosis.
    Dalton CM, Bodini B, Samson RS, Battaglini M, Fisniku LK, Thompson AJ, Ciccarelli O, Miller DH, Chard DT.
    Mult Scler; 2012 Mar 08; 18(3):322-8. PubMed ID: 21878451
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of the natural history and prognostic features of early onset and adult onset multiple sclerosis in Jordanian population.
    El-Salem K, Khader Y.
    Clin Neurol Neurosurg; 2007 Jan 08; 109(1):32-7. PubMed ID: 16870328
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Natural history of multiple sclerosis with childhood onset.
    Renoux C, Vukusic S, Mikaeloff Y, Edan G, Clanet M, Dubois B, Debouverie M, Brochet B, Lebrun-Frenay C, Pelletier J, Moreau T, Lubetzki C, Vermersch P, Roullet E, Magy L, Tardieu M, Suissa S, Confavreux C, Adult Neurology Departments KIDMUS Study Group.
    N Engl J Med; 2007 Jun 21; 356(25):2603-13. PubMed ID: 17582070
    [Abstract] [Full Text] [Related]

  • 19. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.
    Kappos L, Radue EW, O'Connor P, Polman C, Hohlfeld R, Calabresi P, Selmaj K, Agoropoulou C, Leyk M, Zhang-Auberson L, Burtin P, FREEDOMS Study Group.
    N Engl J Med; 2010 Feb 04; 362(5):387-401. PubMed ID: 20089952
    [Abstract] [Full Text] [Related]

  • 20. [Prognostics factors of renal failure in multiple sclerosis].
    Viart L, Elalouf V, Petit J, Al Khedr A, Kristkowiak P, Saint F.
    Prog Urol; 2012 Dec 04; 22(16):1026-32. PubMed ID: 23178100
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.